{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T14:59:15Z","timestamp":1778511555300,"version":"3.51.4"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[1990,9,1]],"date-time":"1990-09-01T00:00:00Z","timestamp":652147200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,6,28]]},"abstract":"<jats:title>SUMMARY<\/jats:title><jats:p>We studied the immunologic correlates of disease activity and differences among subgroups of patients with idiopathic inflammatory myopathy by analysing phenotypic and activation marker expression on peripheral blood mononuclear cells (PBMC). Compared with controls, myositis patients with clinically active disease (n = 51) had significantly lower proportions of CD8- cells and higher proportions of PBMC that expressed DR. CD3- DR, CD14- DR, interlcukin-2 receptors. and the late T cell activation markers CD26 and TLiSA1. TLiSA1 expression, a marker for cytotoxic differentiation, correlated significantly with both clinical activity indices and serum levels of muscle-associated enzymes. In serial studies of seven patients, the proportion of PBMC expressing MHC class II antigen and late T cell activation markers decreased as myositis disease activity decreased, independent of type of therapy. Among the clinical subgroups, polymyositis (n= 21) and inclusion body myositis (n=21) were virtually indistinguishable; dcrmatomyositis patients (n= 19) showed decreased proportions of CD3+DR+ and TLiSA1+ cells, and increased proportions of CD20+ and CD20+ DR+ cells compared with the other two groups. Patients with autoantibodies to histidyl-tRNA synthctasc (Jo-1 antigen. n= 11) had significantly lower proportions of CD3+ andCD4+ cells, lower CD4\/CD8 ratios, and higher proportions of DR+ cells expressing CD20, compared with patients without anti-Jo-1 antibodies. These findings support the concept that activated lymphocytes, especially cells undergoing anamnestic responses and cytotoxic differentiation, are important in the pathogenesis of idiopathic myositis. Moreover, taken together with other studies, these data suggest that groups of patients segregated by clinical or autoantibody status have different mechanisms of systemic immune activation and immunopathology.<\/jats:p>","DOI":"10.1111\/j.1365-2249.1990.tb05341.x","type":"journal-article","created":{"date-parts":[[2010,7,27]],"date-time":"2010-07-27T09:47:52Z","timestamp":1280224072000},"page":"373-379","source":"Crossref","is-referenced-by-count":43,"title":["Lymphocyte activation markers in idiopathic myositis: changes with disease activity and differences among clinical and autoantibody subgroups"],"prefix":"10.1093","volume":"81","author":[{"given":"F W","family":"MILLER","sequence":"first","affiliation":[{"name":"Arthritis and Rheumatism Branch, National Institute of Arthritis and Musculoskeletal and Skin diseases, National Institutes of Health, Bethesda, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L A","family":"LOVE","sequence":"additional","affiliation":[{"name":"Arthritis and Rheumatism Branch, National Institute of Arthritis and Musculoskeletal and Skin diseases, National Institutes of Health, Bethesda, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S A","family":"BARBIERI","sequence":"additional","affiliation":[{"name":"Kidney Disease Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J E","family":"BALOW","sequence":"additional","affiliation":[{"name":"Arthritis and Rheumatism Branch, National Institute of Arthritis and Musculoskeletal and Skin diseases, National Institutes of Health, Bethesda, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P H","family":"PLOTZ","sequence":"additional","affiliation":[{"name":"Arthritis and Rheumatism Branch, National Institute of Arthritis and Musculoskeletal and Skin diseases, National Institutes of Health, Bethesda, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2008,6,28]]},"reference":[{"key":"2022011713331714400_b1","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/ana.410150126","article-title":"Disturbance of regulatory lymphocyte subsets in polymyositis (letter)","volume":"15","author":"Behan","year":"1984","journal-title":"Ann. Neurol."},{"key":"2022011713331714400_b2","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/bmj.287.6386.181","article-title":"Abnormalities of lymphocyte subsets in polymyositis","volume":"287","author":"Behan","year":"1983","journal-title":"Br. med. J."},{"key":"2022011713331714400_b3","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0022-1759(87)90011-1","article-title":"An enzyme-linked immunosorbent assay for the detection and quantitation of anti-Jo-1 antibody in human serum","volume":"98","author":"Biswas","year":"1987","journal-title":"J. immunol. Methods"},{"key":"2022011713331714400_b4","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis (first of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N. Engl. J. Med."},{"issue":"Suppl. 97","key":"2022011713331714400_b5","first-page":"77","article-title":"Isolation of mononuclear cells and granulocytes from human blood","volume":"21","author":"Boyum","year":"1968","journal-title":"Scand. J. clin. Lab. Invest."},{"key":"2022011713331714400_b6","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1084\/jem.161.5.1063","article-title":"TLiSA1, a human T lineage-specific activation antigen involved in the differentiation of cytotoxic T lymphocytes and anomalous killer cells from their precursors","volume":"161","author":"Burns","year":"1985","journal-title":"J. exp. Med."},{"key":"2022011713331714400_b7","first-page":"120","article-title":"Polymyositis and dermatomyositis","volume-title":"Primer on the Rheumatic Diseases","author":"Cronin","year":"1988","edition":"9th edn"},{"key":"2022011713331714400_b8","first-page":"25","article-title":"Abnormalities of the immune system in the idiopathic inflammatory myopathies","volume":"2","author":"Cronin","year":"1988","journal-title":"In Vivo."},{"key":"2022011713331714400_b9","doi-asserted-by":"crossref","first-page":"4832","DOI":"10.1016\/S0021-9258(18)83666-3","article-title":"Specific overproduction of very late antigen 1 integrin in two human neuroblastoma cell lines selected for resistance to detachment by an Arg-Gly Asp-containing synthetic peptide","volume":"264","author":"Dedhar","year":"1989","journal-title":"J. biol. Chem."},{"key":"2022011713331714400_b10","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.1840070623","article-title":"Immunoelectron microscopic observations on the inflammatory infiltrates and HLA antigens in hepatitis B and non-A. non-B","volume":"7","author":"Dines","year":"1987","journal-title":"Hepatology"},{"key":"2022011713331714400_b11","doi-asserted-by":"crossref","first-page":"4233","DOI":"10.4049\/jimmunol.142.12.4233","article-title":"Increment in the Tal + cells in the peripheral blood and thyroid tissue of patients with Graves' disease","volume":"142","author":"Eguchi","year":"1989","journal-title":"J. Immunol."},{"key":"2022011713331714400_b12","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/S0046-8177(86)80180-0","article-title":"Mononuclear cells in myopathies: quantitation of functionally distinct subsets, recognition of antigen-specific cell-mediated cytotoxicity in some diseases, and implications for the pathogenesis of the different inflammatory myopathies","volume":"17","author":"Engel","year":"1986","journal-title":"Hum. Pathol."},{"key":"2022011713331714400_b13","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.4049\/jimmunol.133.3.1250","article-title":"Tal. a novel 105 KD human T cell activation antigen defined by a monoclonal antibody","volume":"133","author":"Fox","year":"1984","journal-title":"J. Immunol."},{"key":"2022011713331714400_b14","doi-asserted-by":"crossref","first-page":"560","DOI":"10.7326\/0003-4819-105-4-560","article-title":"The human interleukin-2 receptor: normal and abnormal expression in T cells and in leukemias induced by the human T-lymphotropic retroviruses (clinical conference)","volume":"105","author":"Greene","year":"1986","journal-title":"Ann. intern. Med."},{"key":"2022011713331714400_b15","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.4049\/jimmunol.142.8.2590","article-title":"Mechanisms of immune memory. T cell activation and CD3 phosphorylation correlates with Ta1 (CDw26) expression","volume":"142","author":"Hafler","year":"1989","journal-title":"J. Immunol."},{"key":"2022011713331714400_b16","doi-asserted-by":"crossref","first-page":"414","DOI":"10.4049\/jimmunol.137.2.414","article-title":"Antigen reactive memory T cells are defined by Ta1","volume":"137","author":"Hafler","year":"1986","journal-title":"J. Immunol."},{"key":"2022011713331714400_b17","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1056\/NEJM198505303122201","article-title":"In vivo activated T lymphocytes in the peripheral blood and cerebrospinal fluid of patients with multiple sclerosis","volume":"312","author":"Hafler","year":"1985","journal-title":"N. Engl. J. Med."},{"key":"2022011713331714400_b18","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/ana.410130413","article-title":"T cell subsets in polymyositis","volume":"13","author":"Iyfr","year":"1983","journal-title":"Ann. Neurol."},{"key":"2022011713331714400_b19","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/anr.1780320414","article-title":"Proliferative response of peripheral blood mononuclear cells to autologous and allogeneic muscle in patients with polymyosilis,' dermatomyositis","volume":"32","author":"Kalovidouris","year":"1989","journal-title":"Arthritis Rheum."},{"key":"2022011713331714400_b20","first-page":"177","article-title":"Immunoperoxidase demonstration of the cellular composition of the normal and coeliac small bowel","volume":"68","author":"Kelly","year":"1987","journal-title":"Clin. exp. Immunol."},{"key":"2022011713331714400_b21","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJM198602063140601","article-title":"Microvascular deposition of complement membrane attack complex in dermatomyositis","volume":"314","author":"Kissel","year":"1986","journal-title":"N. Engl. J. Med."},{"key":"2022011713331714400_b22","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/anr.1780320405","article-title":"Very late activation antigen on synovial fluid T cells from patients with rheumatoid arthritis and other rheumatic diseases","volume":"32","author":"Laffon","year":"1989","journal-title":"Arthritis. Rheum."},{"issue":"D113","key":"2022011713331714400_b23","article-title":"Epidemiology of adult idiopathic inflammatory myopathy: a distinct clinical onset in patients with anti-Jo-1 antibodies","volume":"31","author":"Leff","year":"1988","journal-title":"Arthritis Rheum."},{"key":"2022011713331714400_b24","first-page":"148","article-title":"Causes of idiopathic inflammatory myopathy","volume":"111","author":"Love","year":"1989","journal-title":"Ann. intern. Med."},{"key":"2022011713331714400_b25","first-page":"1423","article-title":"Inclusion body myositis","volume-title":"Myology","author":"Mikol","year":"1986"},{"key":"2022011713331714400_b26","first-page":"150","article-title":"Pathogenesis","volume":"111","author":"Miller","year":"1989","journal-title":"Ann. intern. Med."},{"issue":"B4","key":"2022011713331714400_b27","article-title":"Abnormal lymphocyte trafficking to muscle in patients with idiopathic inflammatory myopathy","volume":"31","author":"Miller","year":"1988","journal-title":"Arthritis Rheum."},{"issue":"Suppl.","key":"2022011713331714400_b28","article-title":"Clinical and autoantibody subgroups predict therapeutic responses and prognosis in the idiopathic inflammatory myopathics","volume":"32","author":"Miller","year":"1989","journal-title":"Arthritis Rheum."},{"issue":"Suppl.","key":"2022011713331714400_b29","first-page":"A126","article-title":"Soluble CDS and interleukin-2 receptor levels are measures of disease activity in the idiopathic inflammatory myopathics","volume":"32","author":"Miller","year":"1989","journal-title":"Arthritis Rheum."},{"key":"2022011713331714400_b30","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1063\/1.1135535","article-title":"Rapid data collection, analysis, and graphics for flow microfluorometry instrumentation","volume":"49","author":"Miller","year":"1978","journal-title":"Rev Sci. Instrum."},{"key":"2022011713331714400_b31","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0090-1229(88)90185-7","article-title":"T lymphocytes compartmentalized on the epithelial surface of the lower respiratory tract express the very late activation antigen complex VLA-1","volume":"46","author":"Saltini","year":"1988","journal-title":"Clin. Immunol. Immunopathol."},{"key":"2022011713331714400_b32","first-page":"494","article-title":"In situ identification of activated Tal+ T lymphocytes in human leprosy skin lesions","volume":"55","author":"Shen","year":"1987","journal-title":"Int. J. Lepr. Mycobact. Dis."},{"key":"2022011713331714400_b33","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/0090-1229(89)90151-7","article-title":"Expression of TLiSA1 on T cells from patients with rheumatoid arthritis and systemic lupus erythematosus","volume":"52","author":"Tabata","year":"1989","journal-title":"Clin. Immunol. Immunopathol."},{"key":"2022011713331714400_b34","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1056\/NEJM197202172860701","article-title":"Vascular deposits of immunoglobulin and complement in idiopathic inflammatory myopalhy","volume":"286","author":"Whitaker","year":"1972","journal-title":"N. Eng. J. Med."},{"key":"2022011713331714400_b35","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0165-5728(87)90108-1","article-title":"Activated T cells in type 1 Charcot Marie-Tooth disease: evidence for immunologic heterogeneity","volume":"16","author":"Williams","year":"1987","journal-title":"J. Neuroimmunol."}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.1990.tb05341.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/81\/3\/373\/42217661\/j.1365-2249.1990.tb05341.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/81\/3\/373\/42217661\/j.1365-2249.1990.tb05341.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T10:39:46Z","timestamp":1685702386000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/81\/3\/373\/6488836"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,9]]},"references-count":35,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2008,6,28]]},"published-print":{"date-parts":[[2008,6,28]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2249.1990.tb05341.x","relation":{},"ISSN":["1365-2249","0009-9104"],"issn-type":[{"value":"1365-2249","type":"electronic"},{"value":"0009-9104","type":"print"}],"subject":[],"published-other":{"date-parts":[[1990,9]]},"published":{"date-parts":[[1990,9]]}}}